Taming Tissue-specific T Cells: CTLA-4 Reins in Self-reactive T Cells

Overview

Journal Nat Immunol

Date 2010 Jan 20

PMID 20084066

Citations 15

Authors

Alison M Paterson

Arlene H Sharpe

Affiliations

Soon will be listed here.

Citing Articles

Abrogation and homeostatic restoration of IgE responses by a universal IgE allergy CTL vaccine-The three signal self/non-self/self (S/NS/S) theory.

Chen S, Zhang H Immunology. 2024; 172(1):91-108.

PMID: 38303079 PMC: 10987285. DOI: 10.1111/imm.13753.

Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.

van Elsas M, van der Schoot J, Bartels A, Steuten K, van Dalen D, Wijfjes Z Int J Mol Sci. 2022; 23(15).

PMID: 35955841 PMC: 9369266. DOI: 10.3390/ijms23158707.

Pigment Epithelium-Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease.

Singh R, Blanco T, Mittal S, Alemi H, Chauhan S, Chen Y Am J Pathol. 2021; 191(4):720-729.

PMID: 33453179 PMC: 8027920. DOI: 10.1016/j.ajpath.2021.01.003.

Epitope prediction and identification- adaptive T cell responses in humans.

Sidney J, Peters B, Sette A Semin Immunol. 2020; 50:101418.

PMID: 33131981 PMC: 7749839. DOI: 10.1016/j.smim.2020.101418.

A Nanobody Against Cytotoxic T-Lymphocyte Associated Antigen-4 Increases the Anti-Tumor Effects of Specific CD8 T Cells.

Tang Z, Mo F, Liu A, Duan S, Yang X, Liang L J Biomed Nanotechnol. 2019; 15(11):2229-2239.

PMID: 31847937 PMC: 9514155. DOI: 10.1166/jbn.2019.2859.

References

Tivol E, Borriello F, Schweitzer A, Lynch W, Bluestone J, Sharpe A . Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3(5):541-7. DOI: 10.1016/1074-7613(95)90125-6. View

Bachmann M, Kohler G, Ecabert B, Mak T, Kopf M . Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol. 1999; 163(3):1128-31. View

Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G . Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939):506-11. DOI: 10.1038/nature01621. View

Schneider H, Downey J, Smith A, Zinselmeyer B, Rush C, Brewer J . Reversal of the TCR stop signal by CTLA-4. Science. 2006; 313(5795):1972-5. DOI: 10.1126/science.1131078. View

Pentcheva-Hoang T, Corse E, Allison J . Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol Rev. 2009; 229(1):67-87. DOI: 10.1111/j.1600-065X.2009.00763.x. View

Fallarino F, Grohmann U, Hwang K, Orabona C, Vacca C, Bianchi R . Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003; 4(12):1206-12. DOI: 10.1038/ni1003. View

Dejean A, Beisner D, Chen I, Kerdiles Y, Babour A, Arden K . Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol. 2009; 10(5):504-13. PMC: 2712214. DOI: 10.1038/ni.1729. View

Fife B, Bluestone J . Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. 2008; 224:166-82. DOI: 10.1111/j.1600-065X.2008.00662.x. View

Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee K . Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995; 270(5238):985-8. DOI: 10.1126/science.270.5238.985. View

10.

Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z . CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008; 322(5899):271-5. DOI: 10.1126/science.1160062. View

11.

Perez V, Van Parijs L, Biuckians A, Zheng X, Strom T, Abbas A . Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 1997; 6(4):411-7. DOI: 10.1016/s1074-7613(00)80284-8. View

12.

Friedline R, Brown D, Nguyen H, Kornfeld H, Lee J, Zhang Y . CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med. 2009; 206(2):421-34. PMC: 2646578. DOI: 10.1084/jem.20081811. View